Author's posts
Fabien Cousteau Is Raising $135 Million To Build The International Space Station Of The Deep Sea
Fabien Cousteau, grandson of famous undersea explorer Jacques-Yves Cousteau, is building on his family legacy by constructing a state-of-the art research facility—60 feet below the surface of the ocean.
These Under 30 Founders Just Raised $15 Million To Make It Easier To Get A Doctor’s Appointment
NexHealth will be expanding its appointment booking, payment processing and API services with the new capital.
Lilly Has Begun Phase 3 Clinical Trials To See If Its Rheumatoid Arthritis Drug Treats Covid-19
The Indianapolis-based pharmaceutical giant hopes to enroll up to 400 people in a study to see if its drug baricitinib can treat patients with severe cases of Covid-19.
The Insider’s Guide To Reopening America
Expert advice for behaving responsibly during the next phase of the pandemic.
AbCellera Raises $105 Million To Boost Drug Discovery Against Coronavirus And Other Diseases
The Vancouver-based biotech firm aims to nearly double its headcount and expand its R&D efforts to find antibodies to treat disease.
Novavax Is Beginning Clinical Trials Of Its Coronavirus Vaccine
Novavax announced it’s beginning clinical trials of its Covid-19 vaccine on Monday.
The Original Plandemic: Unmasking The Eerily Familiar Conspiracy Theories Behind The Russian Flu Of 1889
It doesn’t take Dr. Fauci to know that conspiracy theories have always been a predictable symptom of pandemics.
Large-Scale Clinical Trials Of Mesoblast’s Stem Cell Treatment For COVID-19 Set To Begin Soon
Melbourne-based biotech company Mesoblast will enroll up to 300 COVID-19 patients for a randomized, controlled study of its stem cell therapy.
Gilead’s Antiviral Remdesivir Had A Good Day – But It’s Still Not Clear How Effective It Is Against COVID-19
NIAID head Dr. Anthony Fauci said preliminary data about the drug were positive, on the same day another study showed little benefit from its use.
Gilead’s Antiviral Remdesivir Had A Good Day – But It’s Still Not Clear How Effective It Is Against COVID-19
NIAID head Dr. Anthony Fauci said preliminary data about the drug were positive, on the same day another study showed little benefit from its use.
